SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-041698
Filing Date
2021-08-05
Accepted
2021-08-05 17:02:33
Documents
53
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-10q_20210630.htm   iXBRL 10-Q 1662582
2 EX-10.1 onct-ex101_51.htm EX-10.1 179777
3 EX-10.2 onct-ex102_52.htm EX-10.2 182210
4 EX-10.3 onct-ex103_49.htm EX-10.3 186541
5 EX-31.1 onct-ex311_12.htm EX-31.1 21863
6 EX-31.2 onct-ex312_7.htm EX-31.2 21786
7 EX-32.1 onct-ex321_11.htm EX-32.1 7796
8 EX-32.2 onct-ex322_8.htm EX-32.2 7846
  Complete submission text file 0001564590-21-041698.txt   6118636

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA onct-20210630.xsd EX-101.SCH 46256
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE onct-20210630_cal.xml EX-101.CAL 26437
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE onct-20210630_def.xml EX-101.DEF 106111
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE onct-20210630_lab.xml EX-101.LAB 327419
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE onct-20210630_pre.xml EX-101.PRE 225055
14 EXTRACTED XBRL INSTANCE DOCUMENT onct-10q_20210630_htm.xml XML 874459
Mailing Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 211149297
SIC: 2834 Pharmaceutical Preparations